EMA accepts application of Eisai for two additional indications of anticancer agent lenvatinib in combination with pembrolizumab
Eisai Co., Ltd. announced today that the European Medicines Agency (EMA) has confirmed it has accepted ...
Read moreEisai Co., Ltd. announced today that the European Medicines Agency (EMA) has confirmed it has accepted ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.